These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 16551624)

  • 21. Hsp90 regulates processing of NF-kappa B2 p100 involving protection of NF-kappa B-inducing kinase (NIK) from autophagy-mediated degradation.
    Qing G; Yan P; Qu Z; Liu H; Xiao G
    Cell Res; 2007 Jun; 17(6):520-30. PubMed ID: 17563756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Hsp90 molecular chaperone: an open and shut case for treatment.
    Pearl LH; Prodromou C; Workman P
    Biochem J; 2008 Mar; 410(3):439-53. PubMed ID: 18290764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serine/Threonine Kinase Unc-51-like Kinase-1 (Ulk1) Phosphorylates the Co-chaperone Cell Division Cycle Protein 37 (Cdc37) and Thereby Disrupts the Stability of Cdc37 Client Proteins.
    Li R; Yuan F; Fu W; Zhang L; Zhang N; Wang Y; Ma K; Li X; Wang L; Zhu WG; Zhao Y
    J Biol Chem; 2017 Feb; 292(7):2830-2841. PubMed ID: 28073914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Molecular chaperone HSP90 as a novel target for cancer chemotherapy].
    Miyata Y
    Nihon Yakurigaku Zasshi; 2003 Jan; 121(1):33-42. PubMed ID: 12617036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural studies on the co-chaperone Hop and its complexes with Hsp90.
    Onuoha SC; Coulstock ET; Grossmann JG; Jackson SE
    J Mol Biol; 2008 Jun; 379(4):732-44. PubMed ID: 18485364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of the Hsp90 chaperone cycle by a stringent client protein.
    Lorenz OR; Freiburger L; Rutz DA; Krause M; Zierer BK; Alvira S; Cuéllar J; Valpuesta JM; Madl T; Sattler M; Buchner J
    Mol Cell; 2014 Mar; 53(6):941-53. PubMed ID: 24613341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular chaperone complexes with antagonizing activities regulate stability and activity of the tumor suppressor LKB1.
    Gaude H; Aznar N; Delay A; Bres A; Buchet-Poyau K; Caillat C; Vigouroux A; Rogon C; Woods A; Vanacker JM; Höhfeld J; Perret C; Meyer P; Billaud M; Forcet C
    Oncogene; 2012 Mar; 31(12):1582-91. PubMed ID: 21860411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific association of a set of molecular chaperones including HSP90 and Cdc37 with MOK, a member of the mitogen-activated protein kinase superfamily.
    Miyata Y; Ikawa Y; Shibuya M; Nishida E
    J Biol Chem; 2001 Jun; 276(24):21841-8. PubMed ID: 11278794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional specificity of co-chaperone interactions with Hsp90 client proteins.
    Riggs DL; Cox MB; Cheung-Flynn J; Prapapanich V; Carrigan PE; Smith DF
    Crit Rev Biochem Mol Biol; 2004; 39(5-6):279-95. PubMed ID: 15763706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Mechanism of Hsp90 regulation by the protein kinase-specific cochaperone p50(cdc37).
    Roe SM; Ali MM; Meyer P; Vaughan CK; Panaretou B; Piper PW; Prodromou C; Pearl LH
    Cell; 2004 Jan; 116(1):87-98. PubMed ID: 14718169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure, function and regulation of the hsp90 machinery.
    Li J; Buchner J
    Biomed J; 2013; 36(3):106-17. PubMed ID: 23806880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular determinants of Hsp90 dependence of Src kinase revealed by deep mutational scanning.
    Nguyen V; Ahler E; Sitko KA; Stephany JJ; Maly DJ; Fowler DM
    Protein Sci; 2023 Jul; 32(7):e4656. PubMed ID: 37167432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting the Hsp90-Cdc37-client protein interaction to disrupt Hsp90 chaperone machinery.
    Li T; Jiang HL; Tong YG; Lu JJ
    J Hematol Oncol; 2018 Apr; 11(1):59. PubMed ID: 29699578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hsp90: structure and function.
    Jackson SE
    Top Curr Chem; 2013; 328():155-240. PubMed ID: 22955504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nucleotide-Free sB-Raf is Preferentially Bound by Hsp90 and Cdc37 In Vitro.
    Eckl JM; Daake M; Schwartz S; Richter K
    J Mol Biol; 2016 Oct; 428(20):4185-4196. PubMed ID: 27620500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An acetylation site in the middle domain of Hsp90 regulates chaperone function.
    Scroggins BT; Robzyk K; Wang D; Marcu MG; Tsutsumi S; Beebe K; Cotter RJ; Felts S; Toft D; Karnitz L; Rosen N; Neckers L
    Mol Cell; 2007 Jan; 25(1):151-9. PubMed ID: 17218278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hsp90 promotes kinase evolution.
    Lachowiec J; Lemus T; Borenstein E; Queitsch C
    Mol Biol Evol; 2015 Jan; 32(1):91-9. PubMed ID: 25246701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A hydrophobic segment within the C-terminal domain is essential for both client-binding and dimer formation of the HSP90-family molecular chaperone.
    Yamada S; Ono T; Mizuno A; Nemoto TK
    Eur J Biochem; 2003 Jan; 270(1):146-54. PubMed ID: 12492485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experimentally guided structural modeling and dynamics analysis of Hsp90-p53 interactions: allosteric regulation of the Hsp90 chaperone by a client protein.
    Blacklock K; Verkhivker GM
    J Chem Inf Model; 2013 Nov; 53(11):2962-78. PubMed ID: 24191708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dancing with the Diva: Hsp90-Client Interactions.
    Radli M; Rüdiger SGD
    J Mol Biol; 2018 Sep; 430(18 Pt B):3029-3040. PubMed ID: 29782836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.